F. Bassani

发表

Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain

C. Pietra, I. Rondelli, G. Villetti, 2003, Journal of Pharmacology and Experimental Therapeutics.

Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea‐pig and human airways

G. Villetti, M. Civelli, M. Bergamaschi, 2006, British journal of pharmacology.

Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology

A. Sbarbati, S. Catinella, P. Marzola, 2010, Magnetic Resonance Materials in Physics, Biology and Medicine.

CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration—In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window

A. Sala, S. Catinella, Valentina Bagnacani, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.

S. Catinella, L. Venturi, P. Puccini, 2022, Journal of medicinal chemistry.

CHF6366: characterisation of the bronchoprotective effect of a novel MABA compound in the experimental bronchospasm model in anaesthetised guinea pigs

B. Riccardi, G. Villetti, A. Murgo, 2017 .

Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).

B. Imbimbo, G. Villetti, G. Dondio, 2007, Journal of medicinal chemistry.

CHF3381, a novel antinociceptive agent, attenuates capsaicin-induced pain in rats.

G. Villetti, M. Bergamaschi, F. Bassani, 2005, European journal of pharmacology.

Preclinical Evaluation of CHF3381 as a Novel Antiepileptic Agent

C. Pietra, I. Rondelli, G. Villetti, 2001, Neuropharmacology.

Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor Antagonist

M. Zaniboni, G. Rossoni, G. Villetti, 2010, Journal of Pharmacology and Experimental Therapeutics.

CHF 5407 ) a Potent , Long-Acting and Selective Muscarinic M 3 Receptor Antagonist

G. Villetti, M. Civelli, F. Pastore, 2010 .

Microsoft Word - 1192223-file00

M. Zaniboni, M. Civelli, F. Pastore, 2010 .

Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives.

M. Mazzuferi, G. Villetti, A. Rizzi, 2006, Bioorganic & Medicinal Chemistry.

Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.

S. Catinella, F. Amadei, P. Puccini, 2014, Journal of medicinal chemistry.